PriceTargets.com logo

Aflac - AFL Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $111.00
  • Forecasted Upside: 1.66%
  • Number of Analysts: 11
  • Breakdown:
  • 2 Sell Ratings
  • 6 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$109.19 As of 12/4/2025 04:59 PM ET
▲ +0.146 (0.13%)

This chart shows the closing price for AFL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aflac Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AFL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AFL

Analyst Price Target is $111.00
▲ +1.66% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Aflac in the last 3 months. The average price target is $111.00, with a high forecast of $125.00 and a low forecast of $101.00. The average price target represents a 1.66% upside from the last price of $109.19.

This chart shows the closing price for AFL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in Aflac. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 2 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 3 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 9 hold ratings
  • 3 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 10 hold ratings
  • 2 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 10 hold ratings
  • 2 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 2 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/25/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/19/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/17/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$113.00 ➝ $118.00
11/13/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/7/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$107.00 ➝ $109.00
11/7/2025Evercore ISIBoost TargetUnderperform ➝ Underperform$110.00 ➝ $111.00
11/5/2025BarclaysReiterated RatingUnderweight ➝ Underweight$102.00 ➝ $104.00
11/5/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$100.00 ➝ $101.00
10/9/2025Evercore ISISet TargetUnderperform ➝ Underperform$106.00 ➝ $110.00
10/9/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$108.00 ➝ $110.00
10/8/2025BarclaysReiterated RatingUnderweight ➝ Underweight$100.00 ➝ $102.00
10/8/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
10/7/2025Piper SandlerSet TargetOverweight ➝ Overweight$125.00
9/27/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
8/18/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$108.00 ➝ $113.00
8/14/2025Evercore ISIReiterated RatingUnderperform ➝ Underperform$105.00 ➝ $106.00
8/11/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$105.00 ➝ $107.00
8/11/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$106.00 ➝ $108.00
8/6/2025UBS GroupLower TargetNeutral ➝ Neutral$114.00 ➝ $111.00
7/10/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$103.00 ➝ $105.00
7/8/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$96.00 ➝ $100.00
7/7/2025BarclaysSet TargetUnderweight ➝ Underweight$96.00 ➝ $98.00
5/29/2025Raymond James FinancialLower TargetOutperform ➝ Outperform$115.00 ➝ $110.00
5/19/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$100.00 ➝ $105.00
5/7/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$104.00 ➝ $106.00
5/6/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$102.00 ➝ $103.00
5/1/2025BarclaysBoost TargetUnderweight ➝ Underweight$95.00 ➝ $96.00
4/10/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$105.00 ➝ $100.00
4/2/2025UBS GroupBoost TargetNeutral ➝ Neutral$109.00 ➝ $114.00
4/2/2025Piper SandlerBoost TargetOverweight ➝ Overweight$118.00 ➝ $124.00
4/2/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$94.00 ➝ $96.00
2/28/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$98.00 ➝ $105.00
2/19/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$104.00 ➝ $102.00
2/12/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$107.00 ➝ $104.00
2/7/2025BarclaysLower TargetUnderweight ➝ Underweight$98.00 ➝ $95.00
2/7/2025Piper SandlerLower TargetOverweight ➝ Overweight$122.00 ➝ $118.00
1/23/2025BMO Capital MarketsInitiated CoverageMarket Perform$111.00
1/14/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$103.00 ➝ $104.00
1/10/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$108.00 ➝ $107.00
1/7/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$90.00 ➝ $94.00
1/6/2025BarclaysBoost TargetUnderweight ➝ Underweight$96.00 ➝ $98.00
12/4/2024Evercore ISILower TargetUnderperform ➝ Underperform$104.00 ➝ $102.00
12/3/2024Wells Fargo & CompanyBoost TargetHold ➝ Hold$107.00
11/5/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$106.00 ➝ $107.00
11/1/2024Truist FinancialBoost TargetHold ➝ Hold$100.00 ➝ $105.00
10/10/2024Bank of AmericaBoost TargetBuy ➝ Buy$115.00 ➝ $124.00
10/10/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$90.00 ➝ $106.00
10/9/2024TD CowenInitiated CoverageHold$102.00
10/3/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$85.00 ➝ $90.00
10/2/2024Piper SandlerBoost TargetOverweight ➝ Overweight$114.00 ➝ $122.00
9/26/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$84.00 ➝ $90.00
9/4/2024BarclaysInitiated CoverageUnderweight$96.00
9/4/2024Bank of AmericaBoost TargetBuy ➝ Buy$108.00 ➝ $115.00
8/19/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$91.00 ➝ $98.00
8/14/2024UBS GroupBoost TargetNeutral ➝ Neutral$84.00 ➝ $109.00
8/12/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$81.00 ➝ $90.00
8/2/2024Truist FinancialBoost TargetHold ➝ Hold$82.00 ➝ $100.00
8/1/2024Bank of AmericaBoost TargetBuy ➝ Buy$105.00 ➝ $108.00
7/23/2024CitigroupBoost TargetNeutral ➝ Neutral$84.00 ➝ $93.00
7/11/2024Bank of AmericaBoost TargetBuy ➝ Buy$95.00 ➝ $105.00
7/2/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$80.00 ➝ $83.00
6/28/2024Jefferies Financial GroupLower TargetHold ➝ Hold$84.00 ➝ $83.00
6/28/2024Piper SandlerBoost TargetOverweight ➝ Overweight$95.00 ➝ $100.00
5/10/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$81.00 ➝ $82.00
5/3/2024Truist FinancialBoost TargetHold ➝ Hold$80.00 ➝ $82.00
4/15/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$80.00 ➝ $84.00
4/11/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$83.00 ➝ $81.00
4/10/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$83.00 ➝ $87.00
4/5/2024Piper SandlerBoost TargetOverweight ➝ Overweight$90.00 ➝ $95.00
3/1/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$85.00 ➝ $80.00
2/6/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$82.00 ➝ $83.00
2/2/2024Raymond James FinancialBoost TargetOutperform ➝ Outperform$83.00 ➝ $88.00
1/10/2024UBS GroupBoost TargetNeutral ➝ Neutral$80.00 ➝ $84.00
1/9/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$61.00 ➝ $75.00
1/4/2024Evercore ISIDowngradeIn-Line ➝ Underperform$76.00 ➝ $78.00
11/15/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$75.00 ➝ $80.00
11/2/2023JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$74.00 ➝ $80.00
9/26/2023Raymond James FinancialBoost TargetOutperform ➝ Outperform$77.00 ➝ $83.00
9/14/2023Jefferies Financial GroupBoost TargetHold ➝ Hold$70.00 ➝ $74.00
8/18/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$74.00 ➝ $75.00
8/15/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$71.00 ➝ $78.00
8/9/2023CitigroupBoost TargetNeutral ➝ Neutral$69.00 ➝ $76.00
8/3/2023Truist FinancialBoost TargetHold ➝ Hold$70.00 ➝ $80.00
8/2/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$71.00 ➝ $74.00
8/2/2023JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$72.00 ➝ $74.00
8/2/2023Bank of AmericaBoost Target$79.00 ➝ $86.00
6/9/2023888Reiterated RatingReiterates
6/9/202358.comReiterated RatingReiterates
6/5/2023Bank of AmericaInitiated CoverageBuy ➝ Buy
4/27/2023VNET GroupReiterated RatingMaintains
4/27/2023CitigroupLower Target$73.00 ➝ $69.00
4/25/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$73.00
4/12/2023Morgan StanleyLower TargetOverweight$77.00 ➝ $72.00
2/24/2023Morgan StanleyLower TargetOverweight$78.00 ➝ $77.00
2/6/2023Truist FinancialBoost TargetHold$65.00 ➝ $70.00
2/2/2023Morgan StanleyBoost TargetOverweight$76.00 ➝ $78.00
1/30/2023Raymond James FinancialBoost TargetOutperform$74.00 ➝ $77.00
1/10/2023Morgan StanleyBoost TargetOverweight$72.00 ➝ $76.00
1/6/2023JPMorgan Chase & Co.Boost TargetNeutral$62.00 ➝ $66.00
11/18/2022Piper SandlerBoost TargetOverweight$73.00 ➝ $80.00
11/17/2022Evercore ISISet Target$66.00
11/17/2022Morgan StanleyBoost TargetOverweight$69.00 ➝ $72.00
11/16/2022CitigroupBoost Target$61.00 ➝ $70.00
11/2/2022Royal Bank Of CanadaBoost TargetSector Perform$66.00 ➝ $68.00
11/1/2022Morgan StanleyBoost TargetOverweight$67.00 ➝ $69.00
10/31/2022Raymond James FinancialBoost TargetOutperform$67.00 ➝ $70.00
8/17/2022Morgan StanleyBoost TargetOverweight$66.00 ➝ $67.00
7/11/2022JPMorgan Chase & Co.Boost Target$61.00 ➝ $62.00
7/8/2022Piper SandlerLower TargetOverweight$68.00 ➝ $66.00
7/6/2022Evercore ISILower TargetIn-Line$60.00 ➝ $59.00
7/6/2022Morgan StanleyLower TargetOverweight$69.00 ➝ $66.00
5/23/2022CitigroupInitiated CoverageNeutral$60.00
4/6/2022Piper SandlerBoost TargetOverweight$70.00 ➝ $72.00
2/22/2022Morgan StanleyBoost TargetOverweight$67.00 ➝ $69.00
2/7/2022Raymond James FinancialBoost TargetOutperform$60.00 ➝ $67.00
2/4/2022Truist FinancialBoost Target$53.00 ➝ $63.00
2/4/2022Royal Bank Of CanadaBoost Target$61.00 ➝ $66.00
1/25/2022Jefferies Financial GroupInitiated CoverageHold$60.00
1/21/2022Wolfe ResearchInitiated CoverageMarket Perform$63.00
1/12/2022UBS GroupBoost TargetNeutral$54.00 ➝ $61.00
1/7/2022Morgan StanleyBoost TargetOverweight$66.00 ➝ $67.00
1/5/2022Piper SandlerBoost TargetOverweight ➝ Overweight$63.00 ➝ $67.00
12/2/2021The Goldman Sachs GroupInitiated CoverageSell$52.00
11/17/2021Royal Bank Of CanadaBoost TargetBuy ➝ Sector Perform$59.00 ➝ $61.00
10/14/2021Morgan StanleyBoost TargetOverweight$61.00 ➝ $63.00
5/19/2021Morgan StanleyBoost TargetOverweight$60.00 ➝ $61.00
4/30/2021Truist FinancialBoost Target$48.00 ➝ $54.00
4/30/2021Royal Bank Of CanadaBoost TargetSector Perform$47.00 ➝ $56.00
4/29/2021Morgan StanleyBoost TargetOverweight$58.00 ➝ $60.00
4/26/2021UBS GroupInitiated CoverageNeutral$55.00
4/20/2021UBS GroupInitiated CoverageNeutral$55.00
4/5/2021JPMorgan Chase & Co.Boost TargetCautious ➝ Neutral$51.00 ➝ $55.00
4/1/2021Morgan StanleyBoost TargetOverweight$55.00 ➝ $58.00
3/31/2021CitigroupBoost Target$40.00 ➝ $46.00
2/25/2021Credit Suisse GroupBoost TargetNeutral$40.00 ➝ $48.00
2/25/2021Morgan StanleyBoost TargetOverweight$53.00 ➝ $55.00
2/8/2021Truist FinancialBoost Target$35.00 ➝ $48.00
2/5/2021Royal Bank Of CanadaBoost TargetSector Perform$40.00 ➝ $47.00
1/12/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$53.00
1/8/2021Evercore ISIUpgradeUnderperform ➝ In-Line$43.00 ➝ $47.00
12/4/2020The Goldman Sachs GroupInitiated CoverageSell$43.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.33 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 18 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
Mentions as of
9/5/2025
  • 69 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 5 very negative mentions
Mentions as of
10/5/2025
  • 83 very positive mentions
  • 28 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
Mentions as of
11/4/2025
  • 129 very positive mentions
  • 33 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 129 very positive mentions
  • 33 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Aflac logo
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Read More

Today's Range

Now: $109.19
Low: $109.01
High: $110.14

50 Day Range

MA: $110.35
Low: $105.68
High: $114.96

52 Week Range

Now: $109.19
Low: $96.95
High: $115.83

Volume

2,192,487 shs

Average Volume

2,266,597 shs

Market Capitalization

$57.23 billion

P/E Ratio

14.25

Dividend Yield

2.13%

Beta

0.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Aflac?

The following equities research analysts have issued stock ratings on Aflac in the last year: Barclays PLC, BMO Capital Markets, Evercore ISI, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, Raymond James Financial, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, and Wells Fargo & Company.
View the latest analyst ratings for AFL.

What is the current price target for Aflac?

0 Wall Street analysts have set twelve-month price targets for Aflac in the last year. Their average twelve-month price target is $111.00, suggesting a possible upside of 1.7%. Piper Sandler has the highest price target set, predicting AFL will reach $125.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $101.00 for Aflac in the next year.
View the latest price targets for AFL.

What is the current consensus analyst rating for Aflac?

Aflac currently has 2 sell ratings, 6 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AFL, but not buy more shares or sell existing shares.
View the latest ratings for AFL.

What other companies compete with Aflac?

Other companies that are similar to Aflac include Arch Capital Group, AMERISAFE, Trupanion, Allstate and Employers. Learn More about companies similar to Aflac.

How do I contact Aflac's investor relations team?

Aflac's physical mailing address is 1932 WYNNTON ROAD, COLUMBUS GA, 31999. The financial services provider's listed phone number is (706) 323-3431 and its investor relations email address is [email protected]. The official website for Aflac is www.aflac.com. Learn More about contacing Aflac investor relations.